Will There Ever Be Enough Straws to Break Corporate Health Care Managers' Impunity's Back? - Novartis Settles Yet Again, This Time for Bribing Doctors

Umpteenth verse, same as the first... As just reported by Bloomberg , Novartis AG said it agreed to pay $25 million to settle a U.S. Securi...

Bio-Tech U, Version 2 - Current Board Member of Four Biotechnology Companies, Fomer Pfizer Director, Former Genentech Executive to be President of Stanford

Stanford University will soon have a new president.  According to the New York Times , Stanford University�s incoming president, Marc Tessie...

Health Care Renewal Bloggers in Print on Conflicts of Interest and Health Care Corruption

Not to toot our own horn too loudly, but in the last week, Health Care Renewal bloggers have appeared in print three times. Prevalence of B...

Academic Medical Leaders as Directors of For-Profit Health Care Corporations: the Prevalence of This "New Species" of Conflict of Interest Documented in the BMJ

The important conflicts of interest generated when academic health care leaders also serve on the boards of directors of for-profit health ...

Turn That Door Around - A Physician Substantially Tied to the Pharmaceutical Industry Nominated to Run the FDA

It seems to be the season of the revolving door in health care.  The latest version got some media attention, because it involves one of t...

Who Benefits? - Rising Generic Drug Prices and the Case of Mylan's Conflicted Property Purchases

Rising Generic Drug Prices Health care costs in the US continue their seemingly inexorable rise.  Even the parts of health care that used to...